Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.242NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.449NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.152NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.146NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.64NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.327NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.396NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.129NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.224NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.510NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.91NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.227NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.555NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XACNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used